# ::id 1
# ::snt A single round of treatment with an experimental new medicine appears to be highly effective against a rare form of leukemia and may help fight other kinds of blood cancer as well , says a study published today
(x34 / say-01
	:ARG1 (x22 / and
		:op1 (x11 / appear-02
			:ARG1 (x3 / round
				:mod (x2 / single)
				:consist-of (x5 / treat-03)
				:mod (x10 / medicine
					:mod (x8 / experiment-01)
					:mod (x9 / new)))
			:ARG1 (x15 / effective
				:degree (x14 / high)
				:prep-against (x19 / form
					:mod (x18 / rare)
					:mod (x21 / disease
						:name (n / name
							:op1 "leukemia")))))
		:op2 (x23 / possible
			:domain (x24 / help-01
				:ARG1 (x25 / fight-01
					:ARG1 (x30 / cancer
						:mod (x27 / kind
							:mod (x26 / other))
						:mod (x29 / blood))))))
	:ARG1 (x36 / study-01
		:ARG1-of (x37 / publish-01
			:time (x38 / today))))

# ::id 2
# ::snt The new drug was developed at Scripps Clinic and Research Foundation in La Jolla , Calif. , where doctors tested it on patients with hairy cell leukemia
(x5 / develop-02
	:ARG1 (x3 / drug
		:mod (x2 / new))
	:location (x7 / government-organization
		:name (n / name
			:op1 "Scripps"
			:op2 "Clinic"
			:op3 "and"
			:op4 "Research"
			:op5 "Foundation"))
	:location (x14 / country
		:name (n1 / name
			:op1 "Jolla")
		:null_edge (x13 / country
			:name (n2 / name
				:op1 "La"))
		:null_edge (x16 / country
			:name (n3 / name
				:op1 "Calif."))
		:ARG1-of (x20 / test-01
			:ARG0 (x19 / doctor)
			:ARG2 (x23 / patient
				:ARG1 (x27 / disease
					:name (n4 / name
						:op1 "leukemia")
					:mod (x25 / hairy)
					:mod (x26 / cell))))))

# ::id 3
# ::snt In almost every case , the medicine erased all signs of the disease
(x8 / erase
	:topic (x4 / case
		:mod (x3 / every
			:mod (x2 / almost)))
	:ARG0 (x7 / medicine)
	:ARG1 (x10 / signal-01
		:quant (x9 / all)
		:ARG1 (x13 / disease)))

# ::id 4
# ::snt Hairy cell leukemia affects the white blood cells that make disease-fighting antibodies
(x4 / affect-01
	:ARG0 (x3 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x1 / hairy)
		:ARG1 (x2 / cell))
	:ARG1 (x8 / cell
		:null_edge (x6 / white)
		:mod (x7 / blood)
		:ARG0-of (x10 / make-02
			:ARG1 (x12 / antibody
				:mod (x11 / disease-fighting)))))

# ::id 5
# ::snt Doctors are also testing the drug against chronic lymphocytic leukemia , non-Hodgkins lymphoma and cutaneous T cell lymphoma
(x4 / test-01
	:ARG0 (x1 / doctor)
	:mod (x3 / also)
	:ARG1 (x6 / drug)
	:ARG1 (x14 / and
		:op1 (x10 / disease
			:name (n / name
				:op1 "leukemia")
			:mod (x8 / chronic)
			:mod (x9 / lymphocytic)
			:mod (x12 / organization
				:name (n1 / name
					:op1 "non-Hodgkins")))
		:op2 (x18 / lymphoma
			:ARG1 (x17 / cell
				:mod (x15 / cutaneous)))))

# ::id 6
# ::snt The Scripps doctors concluded that the medicine , called 2-chlorodeoxyadenosine , or 2-CdA , may well be the drug of choice in the treatment of hairy cell leukemia
(x4 / conclude-01
	:ARG0 (x3 / doctor
		:mod (x2 / scripps))
	:ARG1 (x15 / possible
		:domain (x7 / medicine
			:ARG1-of (x9 / call-01
				:ARG2 (x12 / or
					:op1 (x10 / 2-chlorodeoxyadenosine)
					:op2 (x13 / 2-cda))))
		:domain (x19 / drug
			:domain (x24 / treat-03
				:ARG1 (x28 / disease
					:name (n / name
						:op1 "leukemia")
					:mod (x26 / hairy)
					:mod (x27 / cell))))))

# ::id 7
# ::snt The study was directed by Dr. Lawrence D. Piro and published in the New England Journal of Medicine
(x10 / and
	:op1 (x4 / direct-01
		:ARG1 (x2 / study)
		:ARG2 (x7 / name
			:op1 "Lawrence"
			:op2 "D."
			:op3 "Piro"))
	:op2 (x11 / publish-01
		:location (x16 / journal
			:null_edge (x14 / null_tag)
			:poss (x15 / country
				:name (n / name
					:op1 "England"))
			:null_edge (x18 / medicine))))

# ::id 8
# ::snt In their study , doctors gave the drug to 12 patients
(x6 / give-01
	:ARG0 (x3 / study-01)
	:ARG0 (x5 / doctor)
	:ARG1 (x8 / drug)
	:ARG2 (x11 / patient
		:quant 12))

# ::id 9
# ::snt Of these , 11 have remained completely free of all signs of the disease for periods up to four years
(x6 / remain-01
	:ARG1 (x4 / person
		:op 11)
	:ARG3 (x8 / free-01
		:degree (x7 / complete)
		:ARG2 (x11 / sign
			:quant (x10 / all)
			:ARG1 (x14 / disease))
		:ARG2 (x16 / period
			:duration (x20 / temporal-quantity
				:unit (y / year)
				:quant 4))))

# ::id 10
# ::snt The doctors cautioned that longer follow-up will be necessary before they can be sure they have actually cured the disease
(x3 / caution-01
	:ARG0 (x2 / doctor)
	:ARG1 (x6 / follow-up
		:time (x10 / before
			:op1 (x12 / possible
				:domain (x14 / sure)
				:domain (xap0 / and
					:op2 (x18 / cure-01
						:mod (x17 / actual)
						:ARG1 (x20 / disease)))))))

# ::id 11
# ::snt Two other treatments for hairy cell leukemia have been developed in recent years
(x10 / develop-02
	:ARG1 (x3 / treat-03
		:quant 2
		:mod (x2 / other)
		:purpose (x7 / disease
			:name (n / name
				:op1 "leukemia")
			:mod (x5 / hairy)
			:mod (x6 / cell)))
	:time (x13 / temporal-quantity
		:unit (y / year)
		:mod (x12 / recent)))

# ::id 12
# ::snt They are interferon and deoxycoformycin , a drug that is similar to 2-CdA
(x4 / and
	:op1 (x3 / interferon
		:domain (x1 / they))
	:op2 (x5 / deoxycoformycin
		:ARG1 (x8 / drug
			:ARG1-of (x11 / resemble-01
				:op (s / similar)
				:ARG2 (x13 / 2-cda)))))

# ::id 13
# ::snt However , interferon is less effective , and both of those treatments produce serious side effects
(x8 / and
	:op1 (x6 / effective
		:domain (x3 / interferon)
		:degree (x5 / less))
	:op2 (x13 / produce-01
		:ARG3 (x12 / treat-03)
		:ARG1 (x16 / effect-01
			:mod (x14 / serious)
			:mod (x15 / side))))

# ::id 14
# ::snt By contrast , the only unwanted effect of 2-CdA was a few days of fever
(x7 / effect-01
	:beneficiary (x2 / contrast-01)
	:mod (x5 / only)
	:mod (x6 / unwanted)
	:ARG1 (x9 / 2-cda)
	:ARG0 (x15 / fever
		:quant (x12 / few)
		:quant (x13 / temporal-quantity
			:unit (d / day))))

# ::id 15
# ::snt Patients experienced no nausea , hair loss , rashes or other symptoms typical of cancer therapy
(x2 / experience-01
	:ARG0 (x1 / patient)
	:ARG1 (x10 / or
		:op1 (x4 / nausea
			:polarity -)
		:op2 (x7 / loss
			:ARG1 (x6 / hair))
		:op2 (x9 / rash)
		:op2 (x12 / symptom
			:mod (x11 / other)
			:mod (x13 / typify-01
				:domain (x16 / therapy
					:mod (x15 / cancer))))))

# ::id 16
# ::snt Also unlike other treatments , this one appears to work after a single seven-day course of therapy
(x8 / appear-02
	:ARG1 (x4 / treat-03
		:mod (x1 / also)
		:mod (x3 / other))
	:ARG1 (x7 / one
		:mod (x6 / this))
	:ARG1 (x10 / work-01
		:ARG0 x7
		:time (x11 / after
			:op1 (x15 / course-01
				:ARG1 (x17 / therapy)))))

# ::id 17
# ::snt 
(x4 / reach-01
	:ARG0 (x3 / clinic
		:mod (x2 / scripps))
	:ARG1 (x6 / agree-01
		:time (x7 / date-entity)
		:ARG1 (x16 / produce-01
			:ARG1 (x18 / drug
				:ARG1-of (x24 / approve-01
					:time (x23 / yet)
					:ARG1 (x27 / use-01
						:mod (x26 / routine)))))))

